Risks of oral sodium phosphate for precolonoscopy bowel preparation in children

Gastrointestinal Endoscopy

Volumn 65, Issue 7, 2007, Pages 1102-1104

  Hassall, Eric ^a   Lobe, Thom E ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENEMA; MACROGOL 3350; SODIUM DIHYDROGEN PHOSPHATE; X PREP;

CHILD; CLINICAL PRACTICE; COLON LAVAGE; COLONOSCOPY; COMORBIDITY; CONSENSUS; DEHYDRATION; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE DISTURBANCE; ENTERITIS; GASTROENTEROLOGY; HUMAN; HYDRATION; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOKALEMIA; INTESTINE PREPARATION; KIDNEY CALCIFICATION; KIDNEY FAILURE; LETTER; METABOLIC DISORDER; PATIENT ASSESSMENT; PEDIATRICS; PHYSICIAN; PRIORITY JOURNAL; RISK FACTOR; SAFETY; SINGLE DRUG DOSE; TREATMENT INDICATION;

ADMINISTRATION, ORAL; AGE FACTORS; BODY WEIGHT; CATHARTICS; CHILD; COLON; COLONIC DISEASES; COLONOSCOPY; ENEMA; HUMANS; PHOSPHATES; RISK FACTORS;

EID: 34249104492     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.02.046     Document Type: Letter

References (10)

1. Wexner S.D., Beck D.E., Baron T.H., et al. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc 63 (2006) 894-909
2. Barkun A., Chiba N., Enns R., et al. Commonly used preparations for colonoscopy: efficacy, tolerability and safety - a Canadian Association of Gastroenterology position paper. Can J Gastroenterol 20 (2006) 699-710
3. Chan A., Depew W., and Vanner S. Use of oral sodium phosphate colonic lavage solution by Canadian colonoscopists: pitfalls and complications. Can J Gastroenterol 11 (1997) 334-338
4. Shaoul R., Wolff R., Seligman H., et al. Symptoms of hyperphosphatemia, hypocalcemia, and hypomagnesemia in an adolescent after the oral administration of sodium phosphate in preparation for a colonoscopy. Gastrointest Endosc 53 (2001) 650-652
5. Key facts about the safe use of Fleet® Phospho-soda® (sodium phosphates oral solution). Lynchburg (Va): C.B. Fleet Company, Inc. Available at: www.phosphosoda.com/professionals/pdf/KeyFacts.pdf. Accessed April 17, 2007.
6. Johnson & Johnson - MERCK Consumer Pharmaceuticals. Important safety information regarding Fleet® Phospho-soda® (sodium phosphates oral solution). Available at: www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/2002/fleet-phospho-s oda_hpc-cps_e.html. Accessed April 17, 2007.
7. Johnson & Johnson - MERCK Consumer Pharmaceuticals. Reports of renal impairment and nephrocalcinosis with Fleet® Phospho-soda® (sodium phosphates oral solution). Available at: www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/2005/phosphate_solut ions_3_hpc-cps_e.html. Accessed April 17, 2007.
8. Zwas F.R., Cirillo N.W., El-Serag H.B., et al. Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc 43 (1996) 463-466
9. Coskun A., Uzunkoy A., Duzgun S.A., et al. Experimental sodium phosphate and polyethylene glycol induce colonic tissue damage and oxidative stress. Br J Surg 88 (2001) 85-89
10. Atkinson R.J., Save V., and Hunter J.O. Colonic ulceration after sodium phosphate bowel preparation. Am J Gastroenterol 100 (2005) 2603-2605